Optimize postprandial glycemic control with tailored exercise prescriptions

Ab­b­Vie is bet­ting more than $1.9 bil­lion on a French biotech’s long-act­ing in­jectable tech­nol­o­gy. The deal gives Med­in­cell $35 mil­lion up­front and up to $1.9

A dig­i­tal health start­up is jump­ing in to of­fer the lat­est weight loss drug ap­proved by the FDA. Ro, a start­up that pre­scribes and ships